BioWorld Science

RSS

Tecentriq approved in Japan for advanced NSCLC

Jan. 19, 2018

Rexulti tablets approved in Japan for schizophrenia

Jan. 19, 2018

Elobixibat approved in Japan for chronic constipation

Jan. 19, 2018

Eisai licenses ex-Japan rights for E-7046 to Adlai Nortye

Jan. 19, 2018

Fucoidans tested in combination with chemotherapy in cancer models in vivo

Jan. 19, 2018

Janssen initiates phase I trial of JNJ-63733657 in healthy subjects and those with Alzheimer's

Jan. 19, 2018

OPC-64005 studied in phase II trial for utility in adult ADHD

Jan. 19, 2018

Novel mutant IDH1 inhibitors presented by HHS

Jan. 19, 2018

Pfizer's Besponsa approved in Japan for ALL

Jan. 19, 2018

Zhejiang Hisun Pharmaceutical presents new SERAMs for cancer

Jan. 19, 2018